These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35154110)

  • 41. A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague.
    Yamanaka H; Hoyt T; Yang X; Golden S; Bosio CM; Crist K; Becker T; Maddaloni M; Pascual DW
    Infect Immun; 2008 Oct; 76(10):4564-73. PubMed ID: 18694965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protection Induced by Oral Vaccination with a Recombinant
    Majumder S; Olson RM; Singh A; Wang X; Li P; Kittana H; Anderson PE; Anderson DM; Sun W
    Infect Immun; 2022 Aug; 90(8):e0016522. PubMed ID: 35900096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague.
    Sanapala S; Rahav H; Patel H; Sun W; Curtiss R
    Vaccine; 2016 May; 34(21):2410-2416. PubMed ID: 27060051
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Yersinia pestis caf1 variants and the limits of plague vaccine protection.
    Quenee LE; Cornelius CA; Ciletti NA; Elli D; Schneewind O
    Infect Immun; 2008 May; 76(5):2025-36. PubMed ID: 18347051
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague.
    Levy Y; Flashner Y; Tidhar A; Zauberman A; Aftalion M; Lazar S; Gur D; Shafferman A; Mamroud E
    Vaccine; 2011 Sep; 29(40):6866-73. PubMed ID: 21803090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.
    Tiner BL; Sha J; Ponnusamy D; Baze WB; Fitts EC; Popov VL; van Lier CJ; Erova TE; Chopra AK
    Clin Vaccine Immunol; 2015 Dec; 22(12):1255-68. PubMed ID: 26446423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plague in Guinea pigs and its prevention by subunit vaccines.
    Quenee LE; Ciletti N; Berube B; Krausz T; Elli D; Hermanas T; Schneewind O
    Am J Pathol; 2011 Apr; 178(4):1689-700. PubMed ID: 21406168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.
    Philipovskiy AV; Smiley ST
    Infect Immun; 2007 Feb; 75(2):878-85. PubMed ID: 17118978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune defense against pneumonic plague.
    Smiley ST
    Immunol Rev; 2008 Oct; 225():256-71. PubMed ID: 18837787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis.
    Anderson GW; Leary SE; Williamson ED; Titball RW; Welkos SL; Worsham PL; Friedlander AM
    Infect Immun; 1996 Nov; 64(11):4580-5. PubMed ID: 8890210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.
    Boyer JL; Sofer-Podesta C; Ang J; Hackett NR; Chiuchiolo MJ; Senina S; Perlin D; Crystal RG
    Hum Gene Ther; 2010 Jul; 21(7):891-901. PubMed ID: 20180652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb/C mice.
    Wang S; Joshi S; Mboudjeka I; Liu F; Ling T; Goguen JD; Lu S
    Vaccine; 2008 Mar; 26(13):1664-74. PubMed ID: 18291562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospects for new plague vaccines.
    Feodorova VA; Corbel MJ
    Expert Rev Vaccines; 2009 Dec; 8(12):1721-38. PubMed ID: 19943765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of systemic and pneumonic murine models of plague infection using a conditionally virulent strain.
    Mellado-Sanchez G; Ramirez K; Drachenberg CB; Diaz-McNair J; Rodriguez AL; Galen JE; Nataro JP; Pasetti MF
    Comp Immunol Microbiol Infect Dis; 2013 Mar; 36(2):113-28. PubMed ID: 23195858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.
    Wang S; Goguen JD; Li F; Lu S
    Vaccine; 2011 Sep; 29(39):6802-9. PubMed ID: 21199697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of a Cynomolgus Macaque Model of Pneumonic Plague for Evaluation of Vaccine Efficacy.
    Fellows P; Price J; Martin S; Metcalfe K; Krile R; Barnewall R; Hart MK; Lockman H
    Clin Vaccine Immunol; 2015 Sep; 22(9):1070-8. PubMed ID: 26224691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.
    Grosfeld H; Cohen S; Bino T; Flashner Y; Ber R; Mamroud E; Kronman C; Shafferman A; Velan B
    Infect Immun; 2003 Jan; 71(1):374-83. PubMed ID: 12496187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice.
    Anderson GW; Heath DG; Bolt CR; Welkos SL; Friedlander AM
    Am J Trop Med Hyg; 1998 Jun; 58(6):793-9. PubMed ID: 9660466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of bubonic and pneumonic plague using plant-derived vaccines.
    Alvarez ML; Cardineau GA
    Biotechnol Adv; 2010; 28(1):184-96. PubMed ID: 19931370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of Toll-Like Receptor-Specific Agonists on the Host Immune Response to the
    Biryukov S; Dankmeyer JL; Shamsuddin Z; Velez I; Rill NO; Rosario-Acevedo R; Klimko CP; Shoe JL; Hunter M; Ward MD; Cazares LH; Fetterer DP; Bozue JA; Worsham PL; Cote CK; Amemiya K
    Front Immunol; 2021; 12():726416. PubMed ID: 34512658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.